{
    "title": "China perseveres with mRNA COVID shot development amid Omicron, commercial uncertainty",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10559385/China-perseveres-mRNA-COVID-shot-development-amid-Omicron-commercial-uncertainty.html",
    "date": "2022-02-28",
    "keywords": [
        "vaccine",
        "omicron",
        "technology",
        "development",
        "covid19",
        "market",
        "vaccination",
        "health",
        "analyst",
        "booster",
        "rocket",
        "roxanne",
        "liu",
        "stanway",
        "efficacy",
        "china",
        "inc",
        "approach",
        "mrna",
        "ltd",
        "testing",
        "shot",
        "zhao",
        "storage",
        "process",
        "reporting",
        "year",
        "stringent",
        "zerocovid",
        "variant",
        "majority",
        "foreignmade",
        "messenger",
        "rna",
        "drive",
        "home",
        "supply",
        "viability",
        "matter",
        "pride",
        "diplomacy",
        "jaya",
        "dantas",
        "professor",
        "school",
        "population",
        "australia",
        "policy",
        "outbreak",
        "virus",
        "flareup",
        "regime",
        "preomicron",
        "human",
        "duo",
        "pfizer",
        "biontech",
        "se",
        "nonmrna",
        "pair",
        "need",
        "use",
        "date",
        "lockdown",
        "michael",
        "hirson",
        "group",
        "flexibility",
        "containment",
        "impact",
        "economy",
        "commission",
        "science",
        "success",
        "portfolio",
        "june",
        "academy",
        "abogen",
        "biotechnology",
        "co",
        "phase",
        "iii",
        "risk",
        "disease",
        "death",
        "laboratory",
        "study",
        "activity",
        "arcov",
        "production",
        "rate",
        "campaign",
        "export",
        "renaissance",
        "manufacturing",
        "industry",
        "regardless",
        "approval",
        "platform",
        "zhang"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}